Process View
The process in which membrane potential changes in the depolarizing direction from the resting potential, usually from negative to positive. For example, the initial depolarization during the rising phase of an action potential is in the direction from the negative resting potential towards the positive membrane potential that will be the peak of the action potential.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "membrane depolarization"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| DLG4 | discs, large homolog 4 (Drosophila) | 0.970 | Rat | |
| SRC | v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) | 0.957 | ||
| GRB2 | growth factor receptor-bound protein 2 | 0.619 | ||
| GRIN2B | glutamate receptor, ionotropic, N-methyl D-aspartate 2B | 0.574 | Mouse | |
| YWHAZ | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide | 0.494 | Human | |
| CDC42 | cell division cycle 42 (GTP binding protein, 25kDa) | 0.382 | ||
| YWHAB | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta polypeptide | 0.374 | Human | |
| SPRR2A | small proline-rich protein 2A | 0.294 | ||
| WAS | Wiskott-Aldrich syndrome (eczema-thrombocytopenia) | 0.253 | ||
| CAMK2A | calcium/calmodulin-dependent protein kinase II alpha | 0.223 | Human | |
| SMN1 | survival of motor neuron 1, telomeric | 0.197 | Fly | |
| YWHAG | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, gamma polypeptide | 0.196 | Human | |
| YWHAQ | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, theta polypeptide | 0.188 | Human | |
| MAGI3 | membrane associated guanylate kinase, WW and PDZ domain containing 3 | 0.126 | ||
| CALM1 | calmodulin 1 (phosphorylase kinase, delta) | 0.096 | ||
| NEDD4 | neural precursor cell expressed, developmentally down-regulated 4 | 0.085 | Human | |
| SMURF2 | SMAD specific E3 ubiquitin protein ligase 2 | 0.072 | Human | |
| KCNA1 | potassium voltage-gated channel, shaker-related subfamily, member 1 (episodic ataxia with myokymia) | 0.067 | ||
| DLGAP1 | discs, large (Drosophila) homolog-associated protein 1 | 0.065 | ||
| DRD2 | dopamine receptor D2 | 0.064 | ||
| SFN | stratifin | 0.062 | Human | |
| TJP1 | tight junction protein 1 (zona occludens 1) | 0.054 | ||
| PTPN1 | protein tyrosine phosphatase, non-receptor type 1 | 0.051 | ||
| FYN | FYN oncogene related to SRC, FGR, YES | 0.050 | Human | |
| YWHAE | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon polypeptide | 0.048 | Human | |
| HDAC4 | histone deacetylase 4 | 0.046 | ||
| TNK2 | tyrosine kinase, non-receptor, 2 | 0.046 | ||
| SNAP25 | synaptosomal-associated protein, 25kDa | 0.044 | ||
| NLRC4 | NLR family, CARD domain containing 4 | 0.041 | ||
| YAP1 | Yes-associated protein 1 | 0.038 | ||
| MAPT | microtubule-associated protein tau | 0.038 | ||
| YWHAH | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide | 0.037 | ||
| GHR | growth hormone receptor | 0.036 | ||
| ERBB4 | v-erb-a erythroblastic leukemia viral oncogene homolog 4 (avian) | 0.035 | ||
| SNTG2 | syntrophin, gamma 2 | 0.034 | ||
| PTPN11 | protein tyrosine phosphatase, non-receptor type 11 | 0.033 | ||
| BAI1 | brain-specific angiogenesis inhibitor 1 | 0.032 | ||
| BLNK | B-cell linker | 0.032 | ||
| LCK | lymphocyte-specific protein tyrosine kinase | 0.032 | Human | |
| CHDH | choline dehydrogenase | 0.031 | ||
| SMARCA2 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 | 0.031 | ||
| CAMK2B | calcium/calmodulin-dependent protein kinase II beta | 0.031 | Human | |
| KCNA4 | potassium voltage-gated channel, shaker-related subfamily, member 4 | 0.030 | ||
| HCK | hemopoietic cell kinase | 0.029 | Human | |
| KCNB1 | potassium voltage-gated channel, Shab-related subfamily, member 1 | 0.029 | ||
| APP | amyloid beta (A4) precursor protein | 0.028 | ||
| PDCD6IP | programmed cell death 6 interacting protein | 0.027 | ||
| CDK5R1 | cyclin-dependent kinase 5, regulatory subunit 1 (p35) | 0.027 | ||
| SMAD4 | SMAD family member 4 | 0.027 | ||
| AKAP12 | A kinase (PRKA) anchor protein 12 | 0.026 | ||
| PSTPIP1 | proline-serine-threonine phosphatase interacting protein 1 | 0.026 | ||
| NCK1 | NCK adaptor protein 1 | 0.026 | ||
| GRIN2A | glutamate receptor, ionotropic, N-methyl D-aspartate 2A | 0.024 | Mouse Rat | |
| CDKN1A | cyclin-dependent kinase inhibitor 1A (p21, Cip1) | 0.023 | ||
| GRIN2C | glutamate receptor, ionotropic, N-methyl D-aspartate 2C | 0.023 | Mouse | |
| CAV2 | caveolin 2 | 0.023 | ||
| MED28 | mediator complex subunit 28 | 0.023 | ||
| SCNN1B | sodium channel, nonvoltage-gated 1, beta | 0.022 | ||
| ARRDC3 | arrestin domain containing 3 | 0.022 | ||
| KCNC1 | potassium voltage-gated channel, Shaw-related subfamily, member 1 | 0.021 | ||
| GAS7 | growth arrest-specific 7 | 0.020 | ||
| HIPK2 | homeodomain interacting protein kinase 2 | 0.020 | ||
| PPP2CB | protein phosphatase 2, catalytic subunit, beta isozyme | 0.020 | ||
| MDM2 | Mdm2 p53 binding protein homolog (mouse) | 0.019 | ||
| FGR | Gardner-Rasheed feline sarcoma viral (v-fgr) oncogene homolog | 0.019 | Human | |
| WWP2 | WW domain containing E3 ubiquitin protein ligase 2 | 0.018 | Human | |
| TNS4 | tensin 4 | 0.018 | ||
| NRXN1 | neurexin 1 | 0.018 | Mouse | |
| SMURF1 | SMAD specific E3 ubiquitin protein ligase 1 | 0.018 | Human | |
| FRS2 | fibroblast growth factor receptor substrate 2 | 0.017 | ||
| PDE4DIP | phosphodiesterase 4D interacting protein | 0.016 | ||
| ARHGEF7 | Rho guanine nucleotide exchange factor (GEF) 7 | 0.016 | ||
| ACTL6B | actin-like 6B | 0.016 | ||
| SMAD1 | SMAD family member 1 | 0.016 | ||
| WIPF1 | WAS/WASL interacting protein family, member 1 | 0.016 | ||
| MYO16 | myosin XVI | 0.016 | ||
| STMN2 | stathmin-like 2 | 0.015 | ||
| PPP3R1 | protein phosphatase 3, regulatory subunit B, alpha | 0.015 | ||
| CCKBR | cholecystokinin B receptor | 0.014 | ||
| GRIN1 | glutamate receptor, ionotropic, N-methyl D-aspartate 1 | 0.014 | Mouse Rat | |
| PTEN | phosphatase and tensin homolog | 0.014 | Mouse | |
| MATK | megakaryocyte-associated tyrosine kinase | 0.014 | ||
| WWP1 | WW domain containing E3 ubiquitin protein ligase 1 | 0.014 | Human | |
| GRIA4 | glutamate receptor, ionotrophic, AMPA 4 | 0.014 | ||
| ATN1 | atrophin 1 | 0.014 | ||
| APLP1 | amyloid beta (A4) precursor-like protein 1 | 0.014 | ||
| EGFR | epidermal growth factor receptor | 0.013 | ||
| GABRD | gamma-aminobutyric acid (GABA) A receptor, delta | 0.013 | ||
| MEF2A | myocyte enhancer factor 2A | 0.013 | ||
| AMOTL1 | angiomotin like 1 | 0.013 | ||
| PTK2 | PTK2 protein tyrosine kinase 2 | 0.013 | ||
| SLC6A7 | solute carrier family 6 (neurotransmitter transporter, L-proline), member 7 | 0.013 | ||
| LYN | v-yes-1 Yamaguchi sarcoma viral related oncogene homolog | 0.013 | ||
| ATF3 | activating transcription factor 3 | 0.013 | ||
| GRIA2 | glutamate receptor, ionotropic, AMPA 2 | 0.013 | ||
| SOD1 | superoxide dismutase 1, soluble | 0.013 | ||
| LRRK2 | leucine-rich repeat kinase 2 | 0.013 | ||
| CBL | Cas-Br-M (murine) ecotropic retroviral transforming sequence | 0.012 | ||
| PRKCG | protein kinase C, gamma | 0.012 | ||
| FAS | Fas (TNF receptor superfamily, member 6) | 0.012 | ||
| ADORA1 | adenosine A1 receptor | 0.012 | Mouse Rat | |
| DOCK7 | dedicator of cytokinesis 7 | 0.012 | ||
| SH3KBP1 | SH3-domain kinase binding protein 1 | 0.012 | ||
| AR | androgen receptor | 0.012 | ||
| ATRX | alpha thalassemia/mental retardation syndrome X-linked | 0.012 | ||
| MAP2K6 | mitogen-activated protein kinase kinase 6 | 0.012 | ||
| MAPK8IP1 | mitogen-activated protein kinase 8 interacting protein 1 | 0.012 | ||
| EP300 | E1A binding protein p300 | 0.011 | ||
| CAV1 | caveolin 1, caveolae protein, 22kDa | 0.011 | Mouse | |
| CABLES1 | Cdk5 and Abl enzyme substrate 1 | 0.011 | ||
| KRT5 | keratin 5 | 0.011 | ||
| GRIK5 | glutamate receptor, ionotropic, kainate 5 | 0.011 | ||
| GRIA1 | glutamate receptor, ionotropic, AMPA 1 | 0.011 | ||
| DNAJB5 | DnaJ (Hsp40) homolog, subfamily B, member 5 | 0.011 | ||
| RAF1 | v-raf-1 murine leukemia viral oncogene homolog 1 | 0.011 | ||
| TXNIP | thioredoxin interacting protein | 0.011 | ||
| PPP1R9B | protein phosphatase 1, regulatory (inhibitor) subunit 9B | 0.011 | ||
| EPAS1 | endothelial PAS domain protein 1 | 0.011 | ||
| SCN5A | sodium channel, voltage-gated, type V, alpha subunit | 0.011 | ||
| RAPGEF2 | Rap guanine nucleotide exchange factor (GEF) 2 | 0.011 | ||
| LRP6 | low density lipoprotein receptor-related protein 6 | 0.011 | ||
| ARHGAP22 | Rho GTPase activating protein 22 | 0.011 | ||
| FBXL15 | F-box and leucine-rich repeat protein 15 | 0.011 | ||
| MARK1 | MAP/microtubule affinity-regulating kinase 1 | 0.011 | ||
| RBFOX1 | RNA binding protein, fox-1 homolog (C. elegans) 1 | 0.011 | ||
| NGF | nerve growth factor (beta polypeptide) | 0.011 | ||
| CNR1 | cannabinoid receptor 1 (brain) | 0.010 | ||
| SNCA | synuclein, alpha (non A4 component of amyloid precursor) | 0.010 | Mouse | |
| BAI2 | brain-specific angiogenesis inhibitor 2 | 0.010 | ||
| DLG2 | discs, large homolog 2 (Drosophila) | 0.010 | ||
| CD33 | CD33 molecule | 0.010 | ||
| GRIN2D | glutamate receptor, ionotropic, N-methyl D-aspartate 2D | 0.010 | ||
| DLGAP2 | discs, large (Drosophila) homolog-associated protein 2 | 0.010 | ||
| ZFYVE9 | zinc finger, FYVE domain containing 9 | 0.010 | ||
| MAP1B | microtubule-associated protein 1B | 0.010 | ||
| BAD | BCL2-associated agonist of cell death | 0.010 | ||
| ANKRD13A | ankyrin repeat domain 13A | 0.010 | ||
| PSD | pleckstrin and Sec7 domain containing | 0.010 | ||
| SCNN1G | sodium channel, nonvoltage-gated 1, gamma | 0.010 | ||
| UBASH3B | ubiquitin associated and SH3 domain containing B | 0.010 | ||
| SLC9A3R1 | solute carrier family 9 (sodium/hydrogen exchanger), member 3 regulator 1 | 0.010 | ||
| BTK | Bruton agammaglobulinemia tyrosine kinase | 0.010 | Human | |
| IBTK | inhibitor of Bruton agammaglobulinemia tyrosine kinase | 0.010 |